Merrem/Meronem (meropenem) - injectable antibiotic for serious infections including meningitis

Merrem/Meronem (meropenem)


Merrem/Meronem(meropenem) is an ultra-broad spectrum injectable antibiotic for a wide variety of serious infections, including meningitis and pneumonia. AstraZeneca has marketing rights for Merrem/Meronem, which is licensed from Sumitomo Pharmaceuticals Co. Ltd, in most countries outside Japan.

Did you know?

AstraZeneca has a range of product specific and disease area websites for international healthcare professionals and patients. Links to this information can be found below.

Healthcare professionals

Patients and families opens in a new window

Links to country-specific websites can be found using the AstraZeneca websites list.

If you still have a question regarding our drug portfolio you can Contact us.